NCT07086794View on ClinicalTrials.gov

Cocaine and Pentoxifylline (BED IN 47)

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

February 28, 2028

Study Completion Date

February 28, 2028

Conditions
Methamphetamine Use Disorder
Interventions
DRUG

Placebo

The effects of placebo will be determined.

DRUG

Cocaine (IV)

The effects of IV Cocaine will be determined.

DRUG

Pentoxifylline

The effects of pentoxifylline will be determined.

Trial Locations (1)

40507

Psychopharmacology of Addiction Laboratory, Lexington

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

William Stoops

OTHER